Health-related quality of life (HRQoL) encompasses individuals’ subjective health perceptions across physical functioning, psychological status, and social dimensions. In a new study published in Pharmacoeconomics and Policy , a team of researchers in China explores the relationship between catastrophic health expenditure (CHE) and HRQoL among patients with chronic diseases in China. Additionally, the team also looked at the potential benefits of family doctor contract services in reducing the negative effects of CHE.
“Using data from the 2023 Heilongjiang Health Service Survey, we employed Tobit regression and propensity score matching (PSM) to analyze the data,” shares first author Xiangjin Cui. “We found that households facing CHE had significantly lower HRQoL scores (0.743) compared to those without CHE (0.903).”
Notably, CHE was found to have a negative impact on HRQoL, but family doctor services were effective in mitigating this negative effect. Factors like older age, multiple chronic conditions, and high healthcare utilization were associated with lower HRQoL, while higher education and stable employment were protective factors.
“Our findings underscore the vicious cycle of poverty and deteriorating health caused by CHE, suggesting that family doctor contract services can reduce healthcare costs, improve disease management, and enhance overall HRQoL,” adds Cui.
The team recommends expanding such services, especially to vulnerable groups, and integrating them with healthcare insurance to alleviate financial burdens and improve health outcomes for chronic disease patients.
###
Contact the author: Xiangjin Cui, School of Health Management, Harbin Medical University, Harbin, China
The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).
Pharmacoeconomics and Policy
Literature review
Not applicable
The authors declare that there are no conflicts of interest.